FCER2 and diffuse large B-cell lymphoma: Most ofthe CD5+ DLBCL subtypes showed centroblastic morphology and had immunophenotypiccharacteristics of CD5+, CD10−, CD19+, CD20+, CD23−, and cyclin D1−.